Dr LAVERNY Gilles

Fiche personne


coordonnées

IGBMC
1 rue Laurent Fries
BP 10142
67404 ILLKIRCH Cedex

03 88 65 34 68

laverny@igbmc.fr

Territoire

Alsace

Statut

Chercheur

Publications


A vitamin D-based strategy overcomes chemoresistance in prostate cancer.

Len-Tayon K, Beraud C, Fauveau C, Belorusova AY, Chebaro Y, Mouriño A, Massfelder T, Chauchereau A, Metzger D, Rochel N, Laverny G

Br J Pharmacol. 2024 07 9;:

4-Hydroxy-1α,25-Dihydroxyvitamin D: Synthesis and Structure-Function Study.

Peluso-Iltis C, Pierrat N, Rovito D, Osz J, Sawada D, Kittaka A, Laverny G, Rochel N

Biomolecules. 2024 05 3;14(5):

LSD1 inhibition circumvents glucocorticoid-induced muscle wasting of male mice.

Cai Q, Sahu R, Ueberschlag-Pitiot V, Souali-Crespo S, Charvet C, Silem I, Cottard F, Ye T, Taleb F, Metzger E, Schuele R, Billas IML, Laverny G, Metzger D, Duteil D

Nat Commun. 2024 04 26;15(1):3563

Voir plus